119 related articles for article (PubMed ID: 32998070)
1. A 5-year evaluation of using stool-based test for opportunistic colorectal cancer screening in primary health institutions across Malaysia.
Tamin NSI; Razalli KA; Sallahuddin SN; Chan HK; Hassan MRA
Cancer Epidemiol; 2020 Dec; 69():101829. PubMed ID: 32998070
[TBL] [Abstract][Full Text] [Related]
2. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
[TBL] [Abstract][Full Text] [Related]
3. Determinants of colorectal carcinoma screening amongst patients attending a public primary care health centre in Johor Bahru.
Rizky NPH; Aznida FAA; Wan Fadhilah WI
Med J Malaysia; 2021 May; 76(3):346-352. PubMed ID: 34031333
[TBL] [Abstract][Full Text] [Related]
4. Implementation of a home-based colorectal cancer screening intervention in Malaysia (CRC-SIM).
Schliemann D; Ramanathan K; Ibrahim Tamin NSB; O'Neill C; Cardwell CR; Ismail R; Kassim Z; Kee F; Su TT; Donnelly M
BMC Cancer; 2023 Jan; 23(1):22. PubMed ID: 36609260
[TBL] [Abstract][Full Text] [Related]
5. The factors associated with negative colonoscopy in screening subjects with positive immunochemical stool occult blood test outcomes.
Ting PH; Lin XH; Jiang JK; Luo JC; Chen PH; Wang YP; Hsin IF; Perng CL; Hou MC; Lee FY
J Chin Med Assoc; 2018 Sep; 81(9):759-765. PubMed ID: 29778550
[TBL] [Abstract][Full Text] [Related]
6. Overview of colorectal cancer screening programme in Malaysia.
Arunah C; Feisul IM; Nor Saleha IT; Muhammad Radzi AH
Med J Malaysia; 2020 May; 75(3):235-239. PubMed ID: 32467538
[TBL] [Abstract][Full Text] [Related]
7. Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities.
Syed Soffian SS; Safian N; Nawi AM; Ahmad SB; Chan HK; Abu Hassan MR
PLoS One; 2021; 16(10):e0258129. PubMed ID: 34618854
[TBL] [Abstract][Full Text] [Related]
8. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
Lohsiriwat V; Thavichaigarn P; Awapittaya B
J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a Colorectal Carcinoma Screening Program in Kota Setar and Kuala Muda Districts, Malaysia.
Abu Hassan MR; Leong TW; Othman Andu DF; Hat H; Nik Mustapha NR
Asian Pac J Cancer Prev; 2016; 17(2):569-73. PubMed ID: 26925645
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population.
Yang H; Ge Z; Dai J; Li X; Gao Y
Dig Dis Sci; 2011 Jan; 56(1):203-7. PubMed ID: 20458621
[TBL] [Abstract][Full Text] [Related]
11. The Intention and Uptake of Colorectal Cancer Screening after a Brief Health Education Program in a Malaysian Primary Care Setting: A Population-Based Study.
Chan MW; Chean KY; Kader Maideen SF; Kow FP
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3475-3482. PubMed ID: 34837902
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated With Colorectal Cancer Screening Via Immunochemical Fecal Occult Blood Test in an Average-Risk Population From a Multiethnic, Middle-Income Setting.
Bujang NN; Lee YJ; Mohd-Zain SA; Aris JH; Md-Yusoff FA; Suli Z; Abu-Hassan MR; Bhoo-Pathy N
JCO Glob Oncol; 2021 Feb; 7():333-341. PubMed ID: 33625866
[TBL] [Abstract][Full Text] [Related]
13. Facilitators and barriers to colorectal cancer screening using the immunochemical faecal occult blood test among an average-risk population in semi-rural Malaysia: A qualitative study.
Ramanathan K; Schliemann D; Binti Ibrahim Tamin NS; Mohan D; Donnelly M; Su TT
PLoS One; 2022; 17(12):e0279489. PubMed ID: 36580458
[TBL] [Abstract][Full Text] [Related]
14. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
[TBL] [Abstract][Full Text] [Related]
15. Pioneering Annual Colorectal Cancer Screening and Treatment Targeting Low Income Communities in Malaysia (20102015).
Tze CN; Fitzgerald H; Qureshi A; Tan HJ; Low ML
Asian Pac J Cancer Prev; 2016; 17(7):3179-83. PubMed ID: 27509948
[TBL] [Abstract][Full Text] [Related]
16. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
17. Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design.
Juul JS; Bro F; Hornung N; Andersen BS; Laurberg S; Olesen F; Vedsted P
BMC Cancer; 2016 Jul; 16():445. PubMed ID: 27400657
[TBL] [Abstract][Full Text] [Related]
18. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
Meklin J; SyrjÄnen K; Eskelinen M
Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
[TBL] [Abstract][Full Text] [Related]
19. Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting.
Akram A; Juang D; Bustamante R; Liu L; Earles A; Ho SB; Wang-Rodriguez J; Allison JE; Gupta S
Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1265-1270.e1. PubMed ID: 28167157
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer screening among government servants in Brunei Darussalam.
Chong VH; Bakar S; Sia R; Lee J; Kassim N; Rajak L; Abdullah MS; Chong CF
Asian Pac J Cancer Prev; 2013; 14(12):7657-61. PubMed ID: 24460349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
